Lv1
10 积分 2022-02-02 加入
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
3小时前
待确认
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function
1个月前
已关闭
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
1个月前
已完结
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
3个月前
已完结
Aetiology of liver disease and response to immune checkpoint inhibitors: an updated meta-analysis confirms benefit in those with non-viral liver disease
1年前
已完结
P3.04-18 The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis
2年前
已完结
Immunotherapies for hepatocellular carcinoma
2年前
已完结
Spore-Encapsulating Glycosyltransferase Catalysis Tandem Reactions: Facile Chemoenzymatic Synthesis of Complex Human Glycans
2年前
已完结
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
2年前
已完结
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
2年前
已完结
Recent advances in flexible and wearable sensors for monitoring chemical molecules
2年前
已采纳
Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
2年前
已采纳
Evaluation of ocular biometric parameters in keratoconic eyes relative to healthy myopic eyes
2年前
已采纳
皖公网安备34019202002308
